Benson Investment Management Company’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,299
Closed -$3.12M 52
2023
Q1
$3.12M Buy
+20,299
New +$3.35M 1.78% 33

Other funds holding MRNA

Benson Investment Management Company's MRNA Position: Q2 2023 in Review

Benson Investment Management Company sold out of Moderna (MRNA) in Q2 2023, closing a stake of 20,299 shares — an estimated $3.12M sold.

Benson Investment Management Company first reported a position in MRNA in Q1 2023 and held it in 1 quarter. The position peaked at $3.12M in Q1 2023. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Benson Investment Management Company reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Benson Investment Management Company sold 20,299 Moderna shares in Q2 2023, an estimated $3.12M.
  • Benson Investment Management Company first reported a position in Moderna in Q1 2023 and held it in 1 quarter.
  • Benson Investment Management Company's Moderna position peaked at $3.12M in Q1 2023.
  • 966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Benson Investment Management Company's 13F filing for Q2 2023, filed 18 Jul 2023.